Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Lipschitz

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Journal of the American Dietetic Association|June 1, 1995
Appropriate and effective use of the NSI checklist and screens. An update on caring for the elderly by preventing malnutritionA Barrocas, B R Bistrian, G L Blackburn, et al.
Investigational New Drugs|November 11, 1991
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group studyB G Durie, J Crowley, C A Coltman, et al.
American Journal of Clinical Oncology|February 1, 1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group studyD H Ryan, K J Kopecky, D Head, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Journal of the American Dietetic Association|June 1, 1995
Appropriate and effective use of the NSI checklist and screens. An update on caring for the elderly by preventing malnutritionA Barrocas, B R Bistrian, G L Blackburn, et al.
Investigational New Drugs|November 11, 1991
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group studyB G Durie, J Crowley, C A Coltman, et al.
American Journal of Clinical Oncology|February 1, 1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group studyD H Ryan, K J Kopecky, D Head, et al.
Pageof 10